104161
Active immunisation of cats aged 8 weeks and older against feline viral rhinotracheitis to reduce clinical signs; against calicivirus infection to reduce clinical signs and viral excretion; against feline panleucopenia to prevent mortality and reduce clinical signs; and against feline leukaemia to prevent persistent viraemia and reduce clinical signs of the disease. Onsets of immunity have been demonstrated 1 week after primary vaccination course for rhinotracheitis, calicivirus and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. The duration of immunity is 1 year after the last (re)vaccination for rhinotracheitis, calicivirus and feline leukaemia components, and 3 years for panleucopenia component. Dosage and administration 1 ml by subcutaneous injection after reconstitution of the freeze-dried pellet with the solvent, according to the following schedule: Primary vaccination: First injection: from 8 weeks of age, Second injection: 3 to 4 weeks later. Revaccination: For all components one year after the primary vaccination course, then every year for the rhinotracheitis, calicivirosis and feline leukaemia components, and every three years for the panleucopenia component. Where high levels of maternal antibodies against R, C or P components are expected to be present (e.g. in kittens of 9 - 12 weeks of age born from queens which were vaccinated before pregnancy and/or with known or suspected previous exposure to the pathogen(s)), the primary vaccination course should be delayed until 12 weeks of age.
